BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6833474)

  • 1. Selective recovery of oral Capnocytophaga spp. with sheep blood agar containing bacitracin and polymyxin B.
    Mashimo PA; Yamamoto Y; Nakamura M; Slots J
    J Clin Microbiol; 1983 Feb; 17(2):187-91. PubMed ID: 6833474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of Capnocytophaga species with a new selective medium.
    Rummens JL; Fossepre JM; De Gruyter M; Van de Vyver H; Neyt L; Van Landuyt HW
    J Clin Microbiol; 1985 Sep; 22(3):375-8. PubMed ID: 4044796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic content of selective culture media for isolation of Capnocytophaga species from oral polymicrobial samples.
    Ehrmann E; Jolivet-Gougeon A; Bonnaure-Mallet M; Fosse T
    Lett Appl Microbiol; 2013 Oct; 57(4):303-9. PubMed ID: 23725093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective medium for isolation of Actinobacillus actinomycetemcomitans.
    Slots J
    J Clin Microbiol; 1982 Apr; 15(4):606-9. PubMed ID: 7068837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The prevalence and antibiotic susceptibility of Capnocytophaga and Actinobacillus actinomycetemcomitans in the periodontal pockets of periodontitis patients with insulin-independent diabetes mellitus].
    Son SH; Choi SM; Han SB; Chung CP
    Taehan Chikkwa Uisa Hyophoe Chi; 1986 Nov; 24(11):961-8. PubMed ID: 3474309
    [No Abstract]   [Full Text] [Related]  

  • 6. E-test: a new technique for antimicrobial susceptibility testing for periodontal microorganisms.
    Nachnani S; Scuteri A; Newman MG; Avanessian AB; Lomeli SL
    J Periodontol; 1992 Jul; 63(7):576-83. PubMed ID: 1324301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of Capnocytophaga strains to 18 antimicrobial agents.
    Sutter VL; Pyeatt D; Kwok YY
    Antimicrob Agents Chemother; 1981 Aug; 20(2):270-1. PubMed ID: 7283424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibility of Capnocytophaga species to 29 antimicrobial agents.
    Rummens JL; Gordts B; Van Landuyt HW
    Antimicrob Agents Chemother; 1986 Nov; 30(5):739-42. PubMed ID: 3800350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A selective medium for Actinobacillus actinomycetemcomitans and the incidence of the organism in juvenile periodontitis.
    Mandell RL; Socransky SS
    J Periodontol; 1981 Oct; 52(10):593-8. PubMed ID: 7028938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility testing of Danish isolates of Capnocytophaga and CDC group DF-2 bacteria.
    Bremmelgaard A; Pers C; Kristiansen JE; Korner B; Heltberg O; Frederiksen W
    APMIS; 1989 Jan; 97(1):43-8. PubMed ID: 2914105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capnocytophaga.
    Sinnott JT; Cullison JP; Blanco PJ
    Infect Control Hosp Epidemiol; 1988 Apr; 9(4):170-3. PubMed ID: 3361109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth differences of Capnocytophaga canimorsus strains and some other fastidious organisms on various Columbia-based blood agar media.
    Dusch H; Zbinden R; Von Graevenitz A
    Zentralbl Bakteriol; 1995 Oct; 282(4):362-6. PubMed ID: 9810657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocarditis caused by Capnocytophaga ochracea.
    Buu-Hoi AY; Joundy S; Acar JF
    J Clin Microbiol; 1988 May; 26(5):1061-2. PubMed ID: 3384900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medium for selective isolation of Fusobacterium nucleatum from human periodontal pockets.
    Walker CB; Ratliff D; Muller D; Mandell R; Socransky SS
    J Clin Microbiol; 1979 Dec; 10(6):844-9. PubMed ID: 521483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility of Capnocytophaga species to antimicrobial agents.
    Hawkey PM; Smith SD; Haynes J; Malnick H; Forlenza SW
    Antimicrob Agents Chemother; 1987 Feb; 31(2):331-2. PubMed ID: 3566254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibilities and beta-lactamase characterization of Capnocytophaga species.
    Roscoe DL; Zemcov SJ; Thornber D; Wise R; Clarke AM
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2197-200. PubMed ID: 1444299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agar medium for use in susceptibility testing of bacteria from human periodontal pockets.
    Walker CB; Niebloom TA; Socransky SS
    Antimicrob Agents Chemother; 1979 Oct; 16(4):452-7. PubMed ID: 518074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective medium for isolation of Haemophilus somnus from cattle and sheep.
    Slee KJ; Stephens LR
    Vet Rec; 1985 Feb; 116(8):215-7. PubMed ID: 3984199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective medium for the isolation of Haemophilus aphrophilus from the human periodontium and other oral sites and the low proportion of the organism in the oral flora.
    Tempro PJ; Slots J
    J Clin Microbiol; 1986 Apr; 23(4):777-82. PubMed ID: 3700628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of DNA gyrase and topoisomerase IV mutations in fluoroquinolone resistance of Capnocytophaga spp. clinical isolates and laboratory mutants.
    Ehrmann E; Jolivet-Gougeon A; Bonnaure-Mallet M; Fosse T
    J Antimicrob Chemother; 2017 Aug; 72(8):2208-2212. PubMed ID: 28453633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.